Lineage Cell Therapeutics Inc (LCTX) Earning Prediction
Lineage Cell Therapeutics Inc (LCTX) is set to release its earnings performance on 03/11 16:01:00 ET in After Hours trading. Consensus forecasts predict a revenue of 2.30M and an earnings per share (EPS) of -0.07 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
LCTX Transcript
The earnings call reveals mixed signals. Positives include potential $37 million milestone payment from OpRegen, new manufacturing processes, and strategic partnerships. However, the significant net loss, unclear management responses, and reliance on future funding present risks. The Q&A highlights potential expansion with the CIRM grant and partnership strategies, but uncertainties remain. Overall, the sentiment is balanced, leading to a neutral stock price prediction.
The earnings call reflects strong financial performance with significant revenue growth and improved net income. Despite some management hesitance on guidance specifics, the overall sentiment is positive due to increased sales force efforts, higher YCANTH adoption, and robust gross margins. The cash position is solid with upcoming milestone payments. These factors outweigh concerns about market expansion challenges and financial obligations. Given the company's small size, the stock is likely to react positively, potentially in the range of 2% to 8%.
The earnings call indicates increased losses, higher operating expenses, and lack of specific guidance on key projects, which are negative factors. The Q&A reveals management's reluctance to provide clear timelines or specifics, which may concern investors. Despite some positive developments in manufacturing and strategic partnerships, the overall sentiment is negative due to financial performance and uncertainties.
LCTX Report
Frequently Asked Questions
What is the Lineage Cell Therapeutics Inc {quarter} Earnings Release Date and Time?
Lineage Cell Therapeutics Inc (LCTX) is scheduled to release its {quarter} earnings report on Mar 11, 2026, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Lineage Cell Therapeutics Inc {quarter} Revenue and EPS?
Analysts' consensus predicts 2.30M in revenue and an EPS of -0.07 for Lineage Cell Therapeutics Inc's {quarter}.
What Does Intellectia's AI Predict for Lineage Cell Therapeutics Inc {quarter} Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Lineage Cell Therapeutics Inc's {quarter} earnings, with a prediction date of Mar 11, 2026. Lineage Cell Therapeutics Inc {summary}
How Can I Use This Earnings Prediction to Trade LCTX Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Mar 11, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Lineage Cell Therapeutics Inc {quarter}?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
